Keren Shani

Keren Shani is an experienced professional in the field of healthcare and life sciences, currently serving as the Executive Director of Cell & Gene Therapy at Trinity Life Sciences since September 2022. Prior to this role, Keren held various positions at bluebird bio from May 2018 to September 2022, including Senior Director Qualified Treatment Center Strategy & Operations and Director of Commercial Operations. Keren's career also includes leadership in business development at CLJI Worldwide and consulting roles at Trinity Partners and Campbell Alliance. Keren holds a Master of Public Health from Boston University and a Bachelor of Arts in International Relations from Tufts University.